Protagenic Therapeutics, Inc.new (PTIX) stock
PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.36MP/E –Yield –
Protagenic Therapeutics, Inc.new total assets
Total assets on the balance sheet at the end of each period.
Protagenic Therapeutics, Inc.new's total assets was $2.80M at Jun 30, 2026. For fiscal 2024 it was $1.96M, down 54.8% from the year before. The highest annual figure on record is $11.06M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.96M | -54.8% |
| FY2023 | Dec 31, 2023 | $4.32M | -46.2% |
| FY2022 | Dec 31, 2022 | $8.04M | -27.3% |
| FY2021 | Dec 31, 2021 | $11.06M | +1157.9% |
| FY2020 | Dec 31, 2020 | $879.25K | +4.4% |
| FY2019 | Dec 31, 2019 | $842.27K | +20.9% |
| FY2018 | Dec 31, 2018 | $696.88K | -60.9% |
| FY2017 | Dec 31, 2017 | $1.78M | -43.7% |
| FY2016 | Dec 31, 2016 | $3.16M | +1185.3% |
| FY2014 | Jun 30, 2014 | $246.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ1 2026 | Jun 30, 2026 | $2.80M | +8.4% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $1.96M | -54.8% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $1.51M | -72.2% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $1.47M | -78.8% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $2.58M | -66.4% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $4.32M | -46.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $5.43M | -34.2% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $6.92M | -23.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $7.67M | -21.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $8.04M | -27.3% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $8.25M | -29.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $9.01M | -25.3% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $9.80M | +4895.5% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $11.06M | +1157.9% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $11.66M | +1063.4% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $12.06M | +915.4% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $196.14K | -75.0% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $879.25K | +4.4% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $1.00M | +248.8% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $1.19M | +239.6% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $785.85K | +69.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $842.27K | +20.9% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $287.29K | -71.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $349.77K | -68.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $464.78K | -68.4% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $696.88K | -60.9% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $990.45K | -55.4% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $1.09M | -55.5% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $1.47M | -47.0% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $1.78M | -43.7% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $2.22M | -38.1% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $2.45M | -35.2% |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $2.77M | -26.2% |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $3.16M | +1185.3% |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | $3.59M | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | $3.79M | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | $3.75M | – |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | $246.00K | – |
See a number that looks wrong?